Gail M. Farfel - 08 Jun 2022 Form 4 Insider Report for AVROBIO, Inc. (AVRO)

Role
Director
Signature
/s/ Christopher Gerry, Attorney in Fact for Gail M. Farfel
Issuer symbol
AVRO
Transactions as of
08 Jun 2022
Transactions value $
$0
Form type
4
Date filed
10 Jun 2022, 16:39
Previous filing
18 May 2022
Next filing
17 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRO Stock Option (Right to Buy) Award $0 +17.5K $0.00 17.5K 08 Jun 2022 Common Stock 17.5K $1.06 Direct F1
transaction AVRO Stock Option (Right to Buy) Award $0 +17.5K $0.00 17.5K 08 Jun 2022 Common Stock 17.5K $1.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall vest in full upon the earlier of June 8, 2023 or the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the reporting person's continued service as a director through such vesting date.